Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Clinical Trials

Lexicon pharmaceuticals reports phase3 study for sotagliflozin in patients with type 1 diabetes

Clinical Trials
Lexicon Pharmaceuticals announced additional positive data from the Phase 3 inTandem1 study.                        ...

Milestone Pharma Announces Etripamil Phase 2 Clinical Program Success for the Treatment of PSVT

Clinical Trials
Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular compan announced positive data from its Phase 2 NODE-1 trial evaluating etripamil, a novel, potent,...

Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study for Type 2 Diabetes

Clinical Trials
POXEL SA , a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2 diabetes, announced today positive...

Chugai’s phase III ALEX study comparing Alecensa and crizotinib meets primary endpoint

Clinical Trials
Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease worsening (progression-free survival, PFS)...

Kyowa Hakko Kirin Announces Positive Results of the Phase 3 Clinical Study of Mogamulizumab (KW-0761)

Clinical Trials
Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of mogamulizumab (KW-0761)...

Takeda Completes Enrollment of Large Global Phase 3 Trial for Dengue Vaccine Candidate

Clinical Trials
Takeda Pharmaceutical Company Limited announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its global, pivotal Phase 3...

Glenmark Pharma reports positive results from a Phase 3 trial of GSP 301

Clinical Trials
Glenmark Pharmaceuticals, a global pharmaceutical company announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25 mcg) and olopatadine hydrochloride...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.